News and Announcements
YPB Wins Four Year Contract with Mexican National Lottery with an Estimated Value of A$5.6m
- Published July 10, 2017 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
YPB Group (ASX:YPB), a pioneering advanced brand protection solutions company, is pleased to announce that its JV with Affyrmx LLC has been selected by Loteria Nacional Para La Assistencia Publica, Mexico’s National Lottery Office, to supply its register of winning tickets.
KEY TAKEAWAYS:
- The contract with Affyrmx JV in Mexico is a four year agreement supply contract with an estimated value of A$5.6m over term with revenues of A$1.4m per annum.
- Four print runs per week to supply winning ticket registers with specialised security features.
- This has been named the most significant contract win to date in Mexico.
YPB Executive Chairman John Houston said:
“This is the most significant contract we have won in Mexico. The contract win demonstrates the strength of our JV’s relationships in Mexico and our ability to package technology solutions to supply high quality and competitively priced Vital Government Documents. We are honoured to have been selected by Loteria Nacional Para La Assistencia Publica and look forwards to a long and mutually beneficial relationships.”
Company Updates
The Biofilm Breakthrough: How An Australian BioTech Firm Is Tapping Indonesia’s $45,000-a-Kitchen Bottleneck
Australian sustainability and deep-tech firm Altair International Pty Ltd is commercialising plant-based clinical hygiene technology, targeting a prime operational bottleneck in Indonesia’s massive national free meals program. Every few years, an Australian deep-tech company emerges combining proprietary science with a transformational anchor contract, the kind of business that quietly creates an entirely new market category […]
THE TAX CHANGED. NOW THE PRODUCT IS CHANGING TO MATCH.
Changes to the 50% capital gains tax discount are shifting Australian private capital away from growth and into high-yielding wrappers. Fund managers are actively redesigning products across private credit and property to capture the incoming capital rotation
The Algorithm Re-Dosing Cancer Treatment: Inside the University of Melbourne Spin-Out Rewriting a 60-Year-Old Formula
Oncology specialists are still calculating toxic chemotherapy doses using a formula from the era of the Ford Model T, leading to a system where seven out of eight patients are routinely overdosed. University of Melbourne spin-out PredicTx is dismantling this legacy approach, utilizing advanced AI to analyze existing patient CT scans, deliver precision medicine to the bedside, and return a massive 100x financial rerate to hospital networks.
Backed By Leading Investment Groups and Family Offices
